"You are correct in they do need capital, and they themselves have stated it". Would you please point where they said this recently.
The last Qtr showed an N/A for number of quarters of funding on hand. This means they had net inflows over the quarter in the runup to the P2 start.
They also had $8.4m in cash as at 31Dec and are quite clearly well funded through well into the Phase2.
But you are right that the next raise will be with $1+.
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007, page-24
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
83.0¢ |
Change
-0.015(1.78%) |
Mkt cap ! $102.6M | |||
| Open | High | Low | Value | Volume |
| 84.5¢ | 84.5¢ | 80.0¢ | $64.05K | 78.35K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 124 | 83.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 86.0¢ | 6500 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| AGN (ASX) Chart |